Eclipse BioInnovations

5 articles with Eclipse BioInnovations

• Eclipsebio to Present Data and Unveil Antibody Barcode CLIP, a Novel Multiplexed CLIP Technology, at the RNA Society Annual Meeting 2022

  5/24/2022

  Eclipse Bioinnovations, Inc. (Eclipsebio), the leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the presentation of data describing a novel multiplexed cross-linking immunoprecipitation (CLIP) technology, called Antibody Barcode CLIP, at the 27th Annual Meeting of the RNA Society.

• 

  Money on the Move: March 9-15

  3/16/2022

  The companies that got money this week were the ones investing in ambitious, future-looking technologies, such as RNA genomics, biochips and antibody-drug conjugates. 

• Eclipse Bioinnovations to Present New Data on Multiple RNA Genomics Technologies at the RNA Society 2021 Meeting

  5/25/2021

  Eclipse Bioinnovations, a leading RNA genomics company offering technology solutions that accelerate RNA research, will be presenting four scientific posters and a webinar at the RNA Society 2021 annual meeting to be held virtually May 25 through June 4, 2021.

• 

  Untangling the Body’s Smart Sensors: What RNA Binding Proteins Can Tell Us About Gene Regulation

  9/11/2020

  Can you imagine organizing more than 10 terabytes of data into a useful network of information, like creating Google maps from scratch? I certainly can’t, but Eclipse BioInnovations, a San Diego-based biotech start-up, is aiming to do just that for RNA therapeutics.

• Eclipse Cofounders Publish Foundational Dataset Revealing Extensive Hidden Signals in Human Genes

  8/11/2020

  eCLIP technology solved key problem in matching hundreds of RNA binding proteins to the instruction signals within the RNA code to uncover how RNA binding proteins regulate gene expression